IDEXX Laboratories, Inc. logo

IDEXX Laboratories, Inc. (IX1)

Delisted
Want to track IX1 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

IX1 is not paying dividends to its shareholders.
The stock of the company had never split.
The company's stock is traded on 11 different exchanges and in various currencies, with the primary listing on NASDAQ (NGS) (USD).
Third Expansion of IDEXX's Catalyst Platform in Under a Year Delivers Critical Insights to Veterinarians Evaluating Canine Patients for Endocrine Disorders

Third Expansion of IDEXX's Catalyst Platform in Under a Year Delivers Critical Insights to Veterinarians Evaluating Canine Patients for Endocrine Disorders

The Catalyst ® Cortisol Test provides veterinarians with real-time critical insights when evaluating dogs for Addison's disease and Cushing's syndrome WESTBROOK, Maine , June 5, 2025 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced the launch of the Catalyst® Cortisol Test, which measures real-time quantitative cortisol concentrations to support the diagnosis of Addison's disease and diagnosis and management of Cushing's syndrome in dogs. IDEXX's Catalyst Cortisol Test is the third menu expansion in under a year for the Catalyst platform, further advancing the diagnostic capabilities available to veterinary practices at the point-of-care.

Prnewswire | 4 weeks ago
IDEXX Laboratories: Growth Remains Despite Weak Clinical Visits

IDEXX Laboratories: Growth Remains Despite Weak Clinical Visits

IDEXX Laboratories, Inc. delivered strong Q1 FY25 results with 4.7% organic revenue and 7% adjusted EPS growth, despite weak US clinical visits. I see catalysts ahead: potential U.S. tax cuts, normalization of consumer spending, and robust pricing power supporting profit growth. Management guides for 6%-9% organic revenue and 8%-12% adjusted EPS growth in FY25; I model 8.2% revenue growth and margin expansion.

Seekingalpha | 1 month ago
Is IDEXX Laboratories (IDXX) Outperforming Other Medical Stocks This Year?

Is IDEXX Laboratories (IDXX) Outperforming Other Medical Stocks This Year?

Here is how Idexx Laboratories (IDXX) and AngioDynamics (ANGO) have performed compared to their sector so far this year.

Zacks | 1 month ago

IDEXX Laboratories, Inc. Profile

Medical - Diagnostics & Research Industry
Healthcare Sector
Jonathan J. Mazelsky CEO
XETRA Exchange
US45168D1046 ISIN
US Country
11,000 Employees
- Last Dividend
16 Jun 2015 Last Split
21 Jun 1991 IPO Date

Overview

IDEXX Laboratories, Inc., established in 1983 with its headquarters in Westbrook, Maine, is a global leader in the development, manufacturing, and distribution of a broad range of products for various markets including companion animal veterinary, livestock and poultry, dairy, and water testing. With its operations stretching from Africa, the Asia Pacific, Canada, Europe, to Latin America and beyond, IDEXX focuses on enhancing the health and well-being of pets, people, and livestock around the world. The company operates through three distinct segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry, and Dairy. IDEXX's commitment to innovation and quality is evident in its comprehensive product offerings and services, which cater to the diagnostic and health-monitoring needs of these fields.

Products and Services

  • Companion Animal Products:

    Includes a wide range of veterinary diagnostic products such as instruments, consumables, rapid assay test kits, veterinary reference laboratory diagnostic and consulting services, practice management and diagnostic imaging systems. These offerings support veterinarians in delivering high-quality care to companion animals.

  • Livestock, Poultry, and Dairy Products:

    Provides diagnostic and health-monitoring products for the livestock, poultry, and dairy sectors. These products are designed to enhance productivity and health in these industries, ensuring the well-being of animals and the safety of food products.

  • Water Quality Products:

    Offers solutions for the detection of various microbiological contaminants in water. Products like Colilert, Colilert-18, and Colisure tests are developed for quick and accurate detection of total coliforms and E. coli, among other water quality testing solutions.

  • Veterinary Software and Services:

    Provides an array of veterinary software and services that support independent veterinary clinics and corporate groups in managing their operations more efficiently, thereby enhancing patient care and business outcomes.

  • Biomedical Research Products and Services:

    Offers health monitoring, biological materials testing, and laboratory diagnostic instruments and services catering to the biomedical research community. These products support research and development activities in life sciences.

  • Human Medical Products:

    Although primarily focused on animal health, IDEXX also extends its expertise to human medical point-of-care products and laboratory diagnostics services, thereby contributing to the broader field of healthcare.

Contact Information

Address: One IDEXX Drive
Phone: 207 556 0300